Aniracetam vs Armodafinil

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

AniracetamArmodafinil
CategoryNootropicsNootropics
Standard Dose750-1500 mg/day divided into 2-3 doses75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)
TimingWith fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat)Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.
Cycle DurationCycles of 8-12 weeks on, 4 weeks offSame as modafinil; not typically cycled in clinical use.
Evidence Levelmoderate_humanstrong_human
A

Aniracetam

Nootropics

Mechanism

Potent positive allosteric modulator of AMPA receptors with 5-10x the potency of piracetam, slowing both channel closing rate and microscopic desensitization rates. Also modulates metabotropic glutamate receptors (mGluRs), activates nicotinic acetylcholine receptors, and indirectly boosts dopaminergic and serotonergic neurotransmission, conferring anxiolytic properties.

Standard Dosing

750-1500 mg/day divided into 2-3 doses

Timing

With fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat)

Cycle Duration

Cycles of 8-12 weeks on, 4 weeks off

Side Effects

  • Headache (choline depletion)
  • GI discomfort
  • Restlessness
  • Insomnia if taken late

Contraindications

  • Severe hepatic impairment (hepatically metabolized)
  • Known hypersensitivity to racetams

Best Stacking Partners

Alpha-GPCCDP-CholinePiracetamSulbutiamine
B

Armodafinil

Nootropics

Mechanism

The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.

Standard Dosing

75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)

Timing

Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.

Cycle Duration

Same as modafinil; not typically cycled in clinical use.

Side Effects

  • Headache
  • Nausea
  • Dizziness
  • Insomnia (more pronounced than modafinil due to longer half-life)
  • Anxiety
  • Dry mouth
  • Diarrhea
  • Stevens-Johnson syndrome (very rare)

Contraindications

  • Same as modafinil: mitral valve prolapse, left ventricular hypertrophy, severe hepatic impairment, severe anxiety/psychotic disorders, hypersensitivity, pregnancy

Best Stacking Partners

L-TheanineAlpha-GPCMagnesium

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →